Navigation Links
Prostate Cancer Stem Cells Discovered By York Researchers

Researchers at the Yorkshire Cancer Research Unit (YCR) at the University of York in England have found the stem cell that ultimately triggers the development of prostate cancer // . This new finding opens up different possibilities to treat the cancer.

The "parent" stem cell research was carried out by Professor Norman Maitland and Dr Anne Collins. They say that cancer stem cells are no different from normal stem cells in their function. They say that they were able to extract only 0.1 percent of the stem cells from prostate tumors, but this minute number was responsible for directing other cells to turn cancerous. Professor Maitland compares current prostate cancer treatments to cutting off the leaves and trunk of a plant but leaving behind the roots that have the potential to grow back. In essence, if the stem cells were killed off, there is no chance of the cancer returning. "For the first time we have been able to extract these stem cells from prostate cancers, and we are the only people in the world who have been able to propagate them in the laboratory," Maitland said. "We are beginning to understand what they look like. We can now investigate specific therapies for killing the roots, rather than the leaves, of prostate cancers."

Elaine King, chief executive of YCR said that this new development furthered their understanding of tumor stem cells, "This latest discovery will allow YCR scientists to build upon this framework of knowledge, in the hope of developing effective treatments in the future," King said. This research could also open the doors for the treatment of other cancers that have tumor stem cells including brain tumors, breast cancer and colon cancer.

The details of the study appear in Cancer Research, the journal of the American Association for Cancer Research.


'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
(Date:7/25/2008)...on Significant Improvements in Members, Health, A... leader in health,care quality management solution...it has entered into a long-term agreement with Wel...aboration on Quality(SM) Incent and,Reward Best Pr...rk and,primary care clinicians to promote improved...
(Date:7/25/2008)...ire/ -- The Elekta Family of Companies will,showca... at the 2008,American Association of Physicists in... the joint forces of Elekta, IMPAC and CMS are del...d delivery solutions that,streamline the treatment...s, as well as enhance clinician efficiency., "Our...
(Date:7/25/2008)...esophagus can cause immune system changes , ...t evidence linking gastroesophageal reflux disease...versity Medical Center researchers. , An associ...n the 1970s, and since then studies have shown tha...ents also experience GERD symptoms. But the actual...
(Date:7/25/2008)... Retina Group of New York will present an educatio...tion especially designed for seniors. The lecture ...116 Merritts Road, Farmingdale, NY 11735, 1:00 to ... and refreshments will be provided. The phone numb... Hicksville and Hauppauge, NY (...
Breaking Medicine News(10 mins):Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3
...ressed and belong to lower socioeconomic status ha... irrespective of the formula for success//. As per...ncreased level is irrespective of race, age, sex o...ith poverty, per se,’ said lead author Sheldon Coh...
...f the gastrointestinal tract such as gastric bypas... obesity and gastroesophageal reflux// disease res...y presented at the Digestive Disease Week, which r...d physicians from different medical fields such as...
...nearly 15 million Americans suffer Urinary inconti...elief. According to a recent finding//, medical sp...nce in most of the patients with injections made f...After this treatment, the researchers have confirm...
...search into child cancer survivors has revealed th...he chances are twice as much compared// to those w...ypes of cancer survivors, those that have survived...s system tumors run a risk five times more pronoun...
Other Medicine News:Health News:Hormone Levels Increase Due To Socioeconomic Stress 2Health News:Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity 2Health News:Gastric Bypass And Laparoscopic Reflux Surgery Gaining Popularity 3
(Date:7/24/2008)...July 24 /- Alexza,Pharmaceu... it has initiated,its second Phase 3 clinical tria... inhalation product candidate being developed for ...schizophrenia or bipolar disorder.,Alexza believes...kinetic,(PK) properties resulting from inhaled lox...
(Date:7/24/2008)...er designed to take body temperature, for home,and...FirstCall/ --- Kidz-Med, Inc.,(subsidiary of Ameri...United States distributor of the Thermofocus(R) 5-...ce the results of a clinical study,conducted by th...lan, in,Milan, Italy, which proves that the Thermo...
(Date:7/23/2008)...ublication in July print edition of Clinical ...ANAPOLIS, July 23 /- A Roche Diagnost...terminal pro-B-type natriuretic peptide,(NT-proBNP...sk,stratification in predicting the risk of cardio...d with non-steroidal anti-inflammatory drugs of,th...
(Date:7/23/2008)...reas of the Body Have Greater Concentrations of,St...swire-USNewswire/ -- Fat removed,from the lower ab...d to be,an excellent source of stem cells, with hi...the body, reports a Brazilian-based study in Augus...icial medical journal of the,American Society of P...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 1Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 2Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 3Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 4Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 5Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 6Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 7Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 8Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 9Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results 3641 10In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 1In early childhood continuous care by 1 doctor improves delivery of health screenings 13217 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 1FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 2FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 3FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 4FDA Approves Aloxi 28R 29 28Palonosetron HCL 29 Injection for Prevention of Postoperative Nausea and Vomiting 13214 5Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 1Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 2Short RNA strand helps exposed skin cells protect body from bacteria dehydration and even cancer 13210 3
...CO, July 10, 2007 /PRNewswire/ -- Portola,Pharmace...its lead,compound, PRT054021, an oral Factor Xa in...ional Society on Thrombosis and Haemostasis,(ISTH)...hat,PRT054021 was safe, effective, and well tolera...ents (VTE) in patients,undergoing total knee repla...
..., N.J.--(BUSINESS WIRE)--Jul 11, 2007 - Since the ...ine (NEJM) report,that Avandia users are 43 percen...ent more likely to die of cardiovascular causes,th...ysicians intend,to switch many type 2 diabetes pat...ess risk. Research from GfK Market Measures,Event...
Other Medicine Technology:Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3
Horizontal Mini Gel Kit. Gel Bed dimensions: 7.5cm(w) x 10cm(l). Includes one comb and tapered baffles for casting in the unit. Gel bed is UV transparent. Available in clear, blue, yellow, pink,
... gels offer many advantages for nucleic acid separ...cular biologist. Agarose gels are easy to cast and...nderlaying and prevent electrical field discontinu...Horizontal systems are more economical and easier ...
The Mini-Sub cell GT system, with 7 x 10 cm tray, is used for submerged horizontal gel electrophoresis of nucleic acids in mini format 7 x 10 cm agarose gels. The system includes an electrophoresis c
Wide Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 20-well, 32-well, and 2 x 32-well wide mini ReadyAgarose gels
Medicine Products: